Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Lestaurtinib | 0.3 | uM | 1 | VEGF | 1254.0 | 59 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 1 | VEGF | 884.0 | 57 | ||||
N2586 | Tofacitinib | 0.3 | uM | 1 | VEGF | 1116.0 | 63 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | VEGF | 1066.0 | 57 | ||||
N2586 | 1 | VEGF | 1113.0 | 65 | |||||||
RA2159 | Visfatin | 1 | ng/mL | 1 | VEGF | 833.5 | 52 | ||||
RA2159 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 1 | VEGF | 913.0 | 66 | |
RA2159 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | VEGF | 861.0 | 61 | |
RA2159 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | VEGF | 837.0 | 72 | |
RA2159 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | VEGF | 774.0 | 32 | |
RA2159 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 1 | VEGF | 393.5 | 76 | |
N2586 | Visfatin | 1 | ng/mL | 1 | VEGF | 764.0 | 61 | ||||
N2586 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 1 | VEGF | 512.0 | 57 | |
N2586 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | VEGF | 1275.0 | 52 | |
N2586 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | VEGF | 822.0 | 54 | |
N2586 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | VEGF | 663.0 | 41 | |
N2586 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 1 | VEGF | 974.5 | 28 | |
0 | VEGF | 45.0 | 66 | ||||||||
RA2159 | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 881.0 | 49 | ||||
RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 734.0 | 54 | |
RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 646.0 | 60 | |
RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 798.5 | 46 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 861.5 | 42 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 733.0 | 57 | |
N2586 | Poly(I:C) | 2 | ug/mL | 1 | VEGF | 1212.0 | 39 |